<DOC>
	<DOCNO>NCT01783886</DOCNO>
	<brief_summary>To determine efficacy intravitreally ( IVT ) administer VEGF Trap-Eye best-corrected visual acuity ( BCVA ) assess early treatment diabetic retinopathy study ( ETDRS ) chart subject diabetic macular edema ( DME ) central involvement .</brief_summary>
	<brief_title>Efficacy Safety VEGF Trap Eye Diabetic Macular Edema ( DME ) With Central Involvement</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<criteria>Adults â‰¥ 18 year type 1 2 diabetes mellitus Subjects diabetic macular edema ( DME ) secondary diabetes mellitus involve center macula study eye Decrease vision determine primarily result DME study eye Bestcorrected visual acuity ( BCVA ) early treatment diabetic retinopathy study ( ETDRS ) letter score 73 24 ( 20/40 20/320 ) study eye Laser photocoagulation ( panretinal macular ) study eye within 90 day Day 1 More 2 previous macular laser treatment study eye Previous use intraocular periocular corticosteroid study eye within 120 day Day 1 Previous treatment antiangiogenic drug either eye ( pegaptanib sodium , bevacizumab , ranibizumab etc . ) within 90 day Day 1 Active proliferative diabetic retinopathy ( PDR ) study eye Uncontrolled diabetes mellitus , define HbA1c &gt; 12 % Only 1 functional eye even eye otherwise eligible study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Diabetic Macular Edema</keyword>
	<keyword>DME</keyword>
	<keyword>VEGF Trap-Eye</keyword>
	<keyword>best-corrected visual acuity ( BCVA )</keyword>
</DOC>